Pharmaceutical drugs supplied by: Nostrum Laboratories, Inc.
✉ Email this page to a colleague
Nostrum Laboratories, Inc.
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Mpp Pharma | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 040560 | ANDA | Nostrum Laboratories, Inc. | 29033-001-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29033-001-01) | 2020-01-23 |
| Mpp Pharma | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 040560 | ANDA | Nostrum Laboratories, Inc. | 29033-002-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29033-002-01) | 2020-01-23 |
| Chartwell Rx | SUCRALFATE | sucralfate | TABLET;ORAL | 074415 | ANDA | Nostrum Laboratories, Inc. | 29033-003-01 | 100 TABLET in 1 BOTTLE, PLASTIC (29033-003-01) | 2020-02-17 |
| Chartwell Rx | SUCRALFATE | sucralfate | TABLET;ORAL | 074415 | ANDA | Nostrum Laboratories, Inc. | 29033-003-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29033-003-05) | 2020-02-17 |
| Ani Pharms | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 076697 | ANDA | Nostrum Laboratories, Inc. | 29033-004-12 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29033-004-12) | 2020-02-17 |
| Solis Pharms | PIROXICAM | piroxicam | CAPSULE;ORAL | 074118 | ANDA | Nostrum Laboratories, Inc. | 29033-013-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (29033-013-01) | 2020-02-20 |
| Solis Pharms | PIROXICAM | piroxicam | CAPSULE;ORAL | 074118 | ANDA | Nostrum Laboratories, Inc. | 29033-013-05 | 500 CAPSULE in 1 BOTTLE, PLASTIC (29033-013-05) | 2020-02-20 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
